selected publications
- Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of infectious diseases. 2024 Academic Article GET IT
- A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. PLoS pathogens. 2023 Academic Article GET IT
- A bioorthogonal chemical reporter for fatty acid synthase-dependent protein acylation. The Journal of biological chemistry. 2021 Academic Article GET IT